Financial Statements — COAG
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 237.37 | 49.86 |
| Short-term Investments | 220.09 | 113.67 |
| Total Current Assets | 464.00 | 169.43 |
| Property, Plant & Equipment | 0.60 | 0.65 |
| Total Non-current Assets | 1.50 | 1.59 |
| Total Assets | 467.78 | 175.26 |
| Accounts Payable | 6.23 | 5.68 |
| Total Current Liabilities | 12.94 | 13.19 |
| Total Non-current Liabilities* | 0.57 | 0.52 |
| Total Liabilities | 13.51 | 13.71 |
| Retained Earnings | (228.69) | (204.54) |
| Total Stockholder Equity | 454.27 | (198.62) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Research & Development | 20.34 | 19.46 |
| Selling, General & Admin | 5.74 | 4.15 |
| Total Operating Expenses | 26.08 | 23.61 |
| Operating Income | (26.08) | (23.61) |
| Pretax Income | (24.05) | (22.67) |
| Tax Provision | 0.10 | 0.01 |
| Net Income | (24.15) | (22.69) |
| Basic EPS | (0.80) | (23.98) |
| Diluted EPS | (0.80) | (23.98) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (22.64) | (21.58) |
| Capital Expenditures | 0.02 | 0.11 |
| Free Cash Flow* | (22.66) | (21.70) |
| Investing Cash Flow | (107.44) | (15.85) |
| Financing Cash Flow | 317.58 | (0.46) |
* Derived from reported values
